ENPICOM sets a new standard for B cell receptor repertoire analysis
ENPICOM SETS A NEW STANDARD FOR B CELL RECEPTOR REPERTOIRE ANALYSIS ‘s-Hertogenbosch, The Netherlands, December [...]
ENPICOM SETS A NEW STANDARD FOR B CELL RECEPTOR REPERTOIRE ANALYSIS ‘s-Hertogenbosch, The Netherlands, December [...]
TOWARDS A PREDICTABLE COMBINATION THERAPY FOR MULTIPLE CANCER TYPES Glycostem and [...]
Accelerate Your Immunotherapy Target Discovery Using Immune Repertoire Sequencing Dr. Nicola Bonzanni, Chief Scientific Officer [...]
ENPICOM Team Wins Microsoft Genomics Hackathon The ENPICOM Rockstar team, together with the Biocartis team, [...]
Scientific Poster From UKE and ENPICOM Receives Award at Annual Meeting Of DGHO Dr. Donjete [...]
Ronald Burggrave Appointed As Sales Director ENPICOM is pleased to announce the appointment of Ronald [...]
ENPICOM Presents at World Immunotherapy Congress 2018 The World Immunotherapy Congress brings together the pioneers [...]
Nicola Bonzanni, CSO of ENPICOM, Gives Keynote Lecture at ByteMAL Conference 2018 Dr. Nicola Bonzanni, [...]
ENPICOM Receives Eurostars Award On Thursday October 4, 2018, ENPICOM received its Eurostars award for [...]
ENPICOM RELEASES IMMUNE REPERTOIRE SEQUENCING ANALYSIS PLATFORM TO PERSONALIZE IMMUNOTHERAPIES The first version of the [...]